Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:INVX - US4576511079 - Common Stock

21.87 USD
-0.19 (-0.86%)
Last: 12/31/2025, 8:07:57 PM
21.87 USD
0 (0%)
After Hours: 12/31/2025, 8:07:57 PM
Fundamental Rating

7

Taking everything into account, INVX scores 7 out of 10 in our fundamental rating. INVX was compared to 62 industry peers in the Energy Equipment & Services industry. While INVX has a great health rating, its profitability is only average at the moment. INVX is growing strongly while it is still valued neutral. This is a good combination! With these ratings, INVX could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

INVX had positive earnings in the past year.
INVX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INVX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of INVX (8.06%) is better than 85.48% of its industry peers.
Looking at the Return On Equity, with a value of 9.73%, INVX is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.34%, INVX is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.34%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

INVX has a Profit Margin of 10.58%. This is amongst the best in the industry. INVX outperforms 85.48% of its industry peers.
In the last couple of years the Profit Margin of INVX has grown nicely.
With a decent Operating Margin value of 12.21%, INVX is doing good in the industry, outperforming 66.13% of the companies in the same industry.
In the last couple of years the Operating Margin of INVX has grown nicely.
Looking at the Gross Margin, with a value of 32.35%, INVX is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
Compared to 1 year ago, INVX has more shares outstanding
Compared to 5 years ago, INVX has more shares outstanding
INVX has a worse debt/assets ratio than last year.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 6.12 indicates that INVX is not in any danger for bankruptcy at the moment.
The Altman-Z score of INVX (6.12) is better than 100.00% of its industry peers.
The Debt to FCF ratio of INVX is 0.19, which is an excellent value as it means it would take INVX, only 0.19 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.19, INVX belongs to the top of the industry, outperforming 93.55% of the companies in the same industry.
INVX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
INVX has a better Debt to Equity ratio (0.02) than 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 6.12
ROIC/WACC0.95
WACC8.78%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

INVX has a Current Ratio of 4.78. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.78, INVX belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
A Quick Ratio of 2.93 indicates that INVX has no problem at all paying its short term obligations.
INVX has a Quick ratio of 2.93. This is amongst the best in the industry. INVX outperforms 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. Growth

3.1 Past

INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 246.15%, which is quite impressive.
INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
The Revenue has grown by 47.71% in the past year. This is a very strong growth!
INVX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.76% yearly.
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%

3.2 Future

Based on estimates for the next years, INVX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.90% on average per year.
INVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.31% yearly.
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue Next Year94.87%
Revenue Next 2Y42.23%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.02 indicates a rather expensive valuation of INVX.
INVX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.51, INVX is valued at the same level.
Based on the Price/Forward Earnings ratio of 13.41, the valuation of INVX can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 79.03% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.13. INVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.02
Fwd PE 13.41
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVX indicates a slightly more expensive valuation: INVX is more expensive than 62.90% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INVX is valued cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.68
EV/EBITDA 7.88
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as INVX's earnings are expected to grow with 95.77% in the coming years.
PEG (NY)0.05
PEG (5Y)0.19
EPS Next 2Y160.71%
EPS Next 3Y95.77%

0

5. Dividend

5.1 Amount

INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

INNOVEX INTERNATIONAL INC

NYSE:INVX (12/31/2025, 8:07:57 PM)

After market: 21.87 0 (0%)

21.87

-0.19 (-0.86%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)N/A N/A
Inst Owners47.97%
Inst Owner Change0.98%
Ins Owners1.52%
Ins Owner Change-1.14%
Market Cap1.51B
Revenue(TTM)955.34M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (16.6%)
Short Float %N/A
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.29%
PT rev (3m)36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.47%
EPS NY rev (1m)-11.83%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.61%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 23.02
Fwd PE 13.41
P/S 1.58
P/FCF 10.68
P/OCF 8.61
P/B 1.45
P/tB 1.83
EV/EBITDA 7.88
EPS(TTM)0.95
EY4.34%
EPS(NY)1.63
Fwd EY7.46%
FCF(TTM)2.05
FCFY9.37%
OCF(TTM)2.54
OCFY11.61%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.05
PEG (5Y)0.19
Graham Number17.95
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.34%
ROICexc 9.79%
ROICexgc 12.7%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 6.12
F-Score7
WACC8.78%
ROIC/WACC0.95
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%
Revenue Next Year94.87%
Revenue Next 2Y42.23%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year100.38%
EBIT Next 3Y37.48%
EBIT Next 5Y29.59%
FCF growth 1Y326.98%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y586.06%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 8 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.